Akaki CM, Guzmán RAK, Waller GLA, Segura GE

Language: Spanish
References: 19
Page: 212-216
PDF size: 377.99 Kb.

ABSTRACT

Background Recurrent respiratory papillomatosis remains a disease with no cure that causes significant biopsychosocial health impacts in patients, besides representing expenses up to 474,000 dollars for the individual treatment of this disease in a patient whose onset is from infancy. Helicobacter pylori is a bacterium that colonizes the aerodigestive tract, causing inflammation and mucosal damage, factors related to the pathophysiology of recurrent respiratory papillomatosis.
Objective To study the association between the presence of Helicobacter pylori with the clinical course of the recurrent respiratory papillomatosis, to find evidence to justify or not the use of treatment for eradication of this bacterium in patients with recurrent respiratory papillomatosis.
Material and method A subexperimental, observational, prospective study with a consecutive sample of patients with recurrent respiratory papillomatosis, in which presence of H. pylori was studied as well as its association to clinical course of the disease.
Results From our sample of seven patients, only three resulted positive to Helicobacter. When comparing the index relapses/year to the presence of H. pylori we found that there is not a direct association in patients.
Conclusions The presence of H. pylori is not a factor in the course of recurrent respiratory papillomatosis. There is no conclusive data proving the scheme indicate eradication of H. pylori in patients with RRP

REFERENCES

1. Dynamed. Updated 2011 Jun. DynaMed Editorial Team. Helicobacter pylori infection. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed/. Updated 2011 Jun.

2. Ford CN. Paradigms and progress in vocal fold restoration. Laryngoscope 2008;118:1709-1713.

3. Goon P, Sonnex C, Jani P, Stanley M, Sudho H. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol 2008;265:147-151.

4. Johnson. Head & Neck Surgery, Otolaryngology. Capítulos: 43 Pharyngitis; 83 Recurrent Respiratory Papillomatosis. Lippincott Williams & Wilkins.

5. Nagata Pignatari SS, Guzmán Liriano RY, Avelino M, Gurgel Testa JR, et al. Gastroesophageal reflux in patients with recurrent laryngeal papillomatosis. Rev Bras Otorrinolaringol 2007;73:210-214.

6. Stern Y, Felipovich A, Cotton RT, Segal K. Immunocompetency in children with recurrent respiratory papillomatosis: prospective study. Ann Otol Rhinol Laryngol 2007;116:169-171.

7. Portal-Celhay C, Pérez Pérez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clinical Science 2006;110:305-314.

8. Fox M, Forgacs I. Clinical review: Gastro-oesophageal reflux disease. BMJ 2006;332:88-93.

9. Chey WD, Wong BC, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-1825.

10. Schreiber S, Garten D, Sudho H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Otorhinolaryngol 2009;266:17-24.

11. Olivares D, Gisbert JP. Factors involved in the pathogenesis of Helicobacter pylori infection. Service of Digestive Diseases. Hospital Universitario de La Princesa. Madrid, Spain. Rev Esp Enferm Dig 2006;98:374-386.

12. Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after Helicobacter pylori eradication? A meta-analysis. Am J Gastroenterol 2010;105:1007-1013.

13. Corley DA, Kubo A, Levin TR, Block G, et al. Helicobacter pylori and gastroesophageal reflux disease: A community-based study. Helicobacter 2008;13: 352-360.

14. Figura N, Franceschi F, Santucci A, Bernardini G, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2010;15:60-68.

15. Tuan-Jen F, Li-Ang L, Hsueh-Yu L, Chun Y, Chung-Guei H. Helicobacter pylori colonization in the larynges of patients with hoarseness. Laryngoscope 2008;118.

16. Holland BW, et al. Laryngopharyngeal reflux and laryngeal web formation in patients with pediatric recurrent respiratory papillomas. Laryngoscope 2002;112:1926-1929.

17. Oridate N, et al. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms. Laryngoscope 2006;116:547-553.

18. Thibeault S, Rees L, Pazmany L, Birchall LM. At the crossroads: mucosal immunology of the larynx. Mucosal Immunol 2009;2:122-128.

19. Cummings-Craig S, Derkay RA. Faust. Otolaryngology: Head & Neck Surgery. Vol 3. Cap. 204: Recurrent Respiratory Papillomatosis. Mosby, Elsevier, 2010.